gw 274150
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2004 (NCT00273013)
Timeline
Indications
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gw274150
- gw274150
- gw274150
- gw 274150
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00379990 | Phase 2 | Jan 1, 2006 | GlaxoSmithKline |
| NCT00319137 | Phase 2 | Dec 1, 2005 | GlaxoSmithKline |
| NCT00242866 | Phase 2 | Oct 1, 2005 | GlaxoSmithKline |
| NCT00370435 | Phase 2 | Aug 1, 2005 | GlaxoSmithKline |
| NCT00273013 | Phase 1 | Nov 1, 2004 | GlaxoSmithKline |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 5 | 5 | 2 | 2004 |
1 organizations
Page 1 / 1